Compound ID | 3267
Synonym(s): CGP-9000 | CGP9000 | CGP 9000
Class: Beta-lactam (cephalosporin)
Spectrum of activity: | Gram-positive & Gram-negative |
Details of activity: | Active against Staphylococcus aureus, Escherichia coli, Salmonella spp., and Klebsiella pneumoniae; susceptible to hydrolysis by cephalosporinases |
Description: | Synthetic compound; a dihydrophenylglycin derivative of 7-amino-cephalosporanic acid; an orally active cephalosporin; shows better protection than cephalexin in mice infected with Escherichia coli or Pseudomonas aeruginosa |
Year first mentioned: | 1980 |
Development status: | Experimental |
Chemical structure(s): | |
Canonical SMILES: | COC1=C(C(=O)O)N2C(=O)[C@H]([C@H]2SC1)NC(=O)[C@@H](C3=CCC=CC3)N |
Isomeric SMILES: | COC1=C(N2[C@@H]([C@@H](C2=O)NC(=O)[C@@H](C3=CCC=CC3)N)SC1)C(=O)O |
InChI: | InChI=1S/C16H19N3O5S/c1-24-9-7-25-15-11(14(21)19(15)12(9)16(22)23)18-13(20)10(17)8-5-3-2-4-6-8/h2-3,6,10-11,15H,4-5,7,17H2,1H3,(H,18,20)(H,22,23)/t10-,11-,15-/m1/s1 |
InChI Key: | RDMOROXKXONCAL-UEKVPHQBSA-N |
Structure link: | https://pubchem.ncbi.nlm.nih.gov/compound/5284529 |
External links: | |
Guide to Pharmacology: | cefroxadine |
Main Source: | https://journals.asm.org/doi/10.1128/aac.18.1.105 |